官方服务：
资源简介：
Clinical parameters of TNBC subtypes.
应用场景：
创建时间：
2016-06-21
相关数据集
Genomic Regulation of Invasion by STAT3 in Triple Negative Breast Cancer
Breast cancer is a heterogeneous disease comprised of four molecular subtypes defined by whether the tumor-originating cells are luminal or basal epithelial cells. Breast cancers arising from the lumi
NIAID Data Ecosystem70
SMARCA4 loss-of-function induces cisplatin resistance to activate YAP1-dependent epithelial-to-mesenchymal in triple negative breast cancer
We report transcriptome profiling (RNA-seq) for SMARA4 knock-out to elucidate the association with cisplatin-resistance and SMARCA4 loss-of-function using triple negative breast cancer cell lines. Ove
NIAID Data Ecosystem50
Keratin 19 binds and regulates cytoplasmic HNRNPK mRNA targets in triple-negative breast cancer. Keratin 19 binds and regulates cytoplasmic HNRNPK mRNA targets in triple-negative breast cancer
This study identifies how a cytoskeletal protein can directly regulate gene expression by controlling the subcellular localization of RNA-binding proteins to support pathways involved in cancer progre
NIAID Data Ecosystem30
ChIP-seq of E4F1 in SUM159 triple negative breast cancer cell line
E4F1 is a ubiquitously expressed zinc-finger protein of the Gli-Kruppel family that was first identified, more than 30 years ago, as a cellular target of the adenoviral oncoprotein E1A13S (Ad type V),
NIAID Data Ecosystem60
Supplementary Materials - Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
Aims. According to the need for the development of new anticancer agents, we have synthetized novel bioactive compounds and aimed to determine their antitumor action. Materials & Methods. We d
DataCite Commons2024-05-18 更新40
